title: CLINICAL IMPACT IN THE MANAGEMENT OF NEOVASCULAR GLAUCOMA.
abstract: BACKGROUND
  Neovascular glaucoma (NVG), participates in the group of secondary glaucoma causing the-increase of intraocular pressure (IOP) as a result of iridocorneal angle enclosure with the development of neovase derived from the retinal ischemic and other inflamatory diseases.
  
  
  OBJECTIVE
  Is to show the incidence, etiopathogenesis, clinical development and the management of NVG by comparing the contemporary and referring literature to other clinics.
  
  
  METHODS
  In this study there were presented the results of NVG treatment for the 2010- 2014 interval. The data processing were conducted using statistically package SPSS 22.
  
  
  RESULTS
  In this scientific study were included 61 patients with NVG containing 4.3% of all cases with glaucoma and 14% of cases with secondary glaucoma, aged 22-79. The mean age of the patients was 60.9 year (SD + 10.6 year), 39 cases or 63.9% were of masculine gender and 22 cases or 36.1% of feminine gender, as it seems there is a differentiation with a statistical significance (X2 = 4.74, P = 0.03, therefore P < 0.05). The most frequent cause of NVG was PDR in 55 cases or 55.6% of them, then, ischemic CRVO with 11 cases or 11.1%. The most frequent complications to the NVG were hemophthalmos, cataract and absolute glaucoma.
  
  
  CONCLUSIONS
  In many aspects our results were in line with the results of other authors. Therefore we should focus on the adequate treatment of ocular ischemic in time, as it is only prevention method of NVG.
authors.forename: Halil
authors.initials: H
authors.lastname: Ajvazi
authors.forename: Pajtim
authors.initials: P
authors.lastname: Lutaj
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D000415:Albania / Q000453:epidemiology; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D005260:Female; D005901:Glaucoma / Q000175:diagnosis / Q000628:therapy; D015355:Glaucoma, Neovascular / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D006801:Humans; D015994:Incidence; D063826:Kosovo / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D017678:Sex Distribution; D014130:Trabeculectomy / Q000379:methods; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors